½ÃÀ庸°í¼­
»óǰÄÚµå
1591854

°¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° À¯Çü, Åõ¼® À¯Çü, Ä¡·á À¯Çüº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Home Dialysis Systems Market by Product (Consumables, Device), Dialysis Type (Hemodialysis, Peritoneal Dialysis), Disease Treatment Type - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀåÀº 2023³â¿¡ 223¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 245¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 10.53%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 450¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀåÀº ȯÀÚÀÇ Áý¿¡¼­ Åõ¼® ÀýÂ÷¸¦ ¼öÇàÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±â ¹× ÀåÄ¡·Î ±¸¼ºµÇ¾î ºó¹øÇÑ ÀÓ»ó ¹æ¹®ÀÇ Çʿ伺À» Á¦°ÅÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡´Â ÁÖ·Î º¹¸· Åõ¼®±â¿Í °¡Á¤¿ë Ç÷¾× Åõ¼®±â°¡ Æ÷ÇԵ˴ϴÙ. ½ÅÀå ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÀçÅÃÄ¡·á ¼­ºñ½º¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡´Â ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ Çʿ伺À» µÞ¹ÞħÇÕ´Ï´Ù. ȯÀÚ°¡ Áý¿¡¼­ ÇÊ¿äÇÑ Ä¡·á¸¦ ¹ÞÀ¸¸é¼­µµ Áý¿¡¼­¿Í °°Àº Æí¸®ÇÔ°ú Æí¾ÈÇÔÀ» ´©¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿¡´Â °³ÀΠȯÀÚ, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü, ÀçÅÃÄ¡·á ±â°üÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ÀçÅà Åõ¼®ÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¿ø°Ý ÀÇ·áÀÇ ¹ßÀü, Á¤ºÎÀÇ Áö¿ø Á¤Ã¥, IoT ¹× AI ±â¹Ý ½Ã½ºÅÛ°ú °°Àº ±â¼ú ÅëÇÕ¿¡ ´ëÇÑ »õ·Î¿î ±âȸ°¡ Á¸ÀçÇÏ¿© ´õ ³ªÀº ¸ð´ÏÅ͸µ ¹× ¿¹Ãø À¯Áö º¸¼ö¸¦ º¸ÀåÇÏ¿© ȯÀÚ °á°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Ãʱ⠺ñ¿ë, °³¹ßµµ»ó±¹ÀÇ È¯ÀÚ ÀÎ½Ä ºÎÁ·, ÀáÀçÀûÀÎ ±ÔÁ¤ Áؼö ¹× ¾ÈÀü ¹®Á¦¿Í °°Àº °úÁ¦µµ ³²¾Æ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »óȯ ¹®Á¦ ¹× ¼÷·ÃµÈ °£º´ÀÎÀÇ Çʿ伺ÀÌ ½ÃÀå ħÅõ¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ±Øº¹Çϱâ À§ÇØ ±â¾÷µéÀº ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç °³¹ß, »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º °­È­, ȯÀÚ ¹× ÀÇ·áÁø ÀÎ½Ä Á¦°í¸¦ À§ÇÑ ±³À° ÀÌ´Ï¼ÅÆ¼ºê È®´ë µî Çõ½Å¿¡ ÃÊÁ¡À» ¸ÂÃß¾î¾ß ÇÕ´Ï´Ù. ±â±â ¼ÒÇüÈ­ ¹× ¿þ¾î·¯ºí Åõ¼® ½Ã½ºÅÛ °³¼±¿¡ ´ëÇÑ ¿¬±¸´Â °æÀï ¿ìÀ§¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå ¿ªÇÐÀº ¿ªµ¿ÀûÀ̰í Á¡Á¡ ´õ ±â¼ú Áß½ÉÀûÀ̸ç, ȯÀÚ Áß½ÉÀÇ Çõ½Å°ú ÀÇ·á ÀÎÇÁ¶ó °³¼±À¸·Î Å©°Ô ¼ºÀåÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ±â¼ú ±â¾÷ ¹× ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Çù·ÂÀº Á¦Ç° °³¼±À» ÃËÁøÇÏ°í ½ÃÀå ÁøÀÔÀÇ ÆøÀ» ³ÐÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌÇØ°ü°èÀÚµéÀº ±ÔÁ¦ °¡À̵å¶óÀÎÀ» ÁؼöÇϰí, Çõ½ÅÀ» ÃËÁøÇϰí Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϱâ À§ÇÑ ¿¬±¸°³¹ß Ȱµ¿¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 223¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 245¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 450¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 10.53%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

°¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àü ¼¼°è ¸¸¼º ½ÅÀå ÁúȯÀÇ À¯º´·ü Áõ°¡
    • ȯÀÚÀÇ ÆíÀǼº°ú À¯¿¬¼ºÀ¸·Î ÀÎÇÑ ´ëÆøÀûÀÎ È®»ê
    • ÀçÅà Åõ¼®¿¡ À¯¸®ÇÑ Á¤ºÎ ÇÁ·Î±×·¥
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ°ú °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • Çõ½ÅÀûÀ̰í Áøº¸µÈ ÀçÅà Åõ¼® ½Ã½ºÅÛÀÇ µîÀå
    • ÀçÅà Åõ¼® ½Ã½ºÅÛ¿¡¼­ ¼ÒºñÀÚ Ä£È­Àû ±â¼ú µµÀÔ
  • ½ÃÀå °úÁ¦
    • °¡Á¤ Åõ¼®º¸´Ù ¼¾ÅÍ Åõ¼®¿¡ ´ëÇÑ ³ôÀº ¼±È£µµ

Portre's Five Forces: °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

°¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

°¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

°¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • ¼Ò¸ðǰ
    • Ç÷Åë
    • Ä«Å×ÅÍ
    • ³óÃ๰
  • µð¹ÙÀ̽º
    • Åõ¼® Àåºñ
    • ±â°è
    • ¼öó¸® ½Ã½ºÅÛ

Á¦7Àå °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå : Åõ¼® À¯Çüº°

  • Ç÷¾× Åõ¼®
    • ±âÁ¸
    • ¾ß°£ Ç÷¾× Åõ¼®
    • ´Ü±â Åõ¼®
  • º¹¸· Åõ¼®
    • ¿Ü·¡ º¹¸· Åõ¼®
    • Áö¼ÓÀû ÈÞ´ëÇü º¹¸· Åõ¼®

Á¦8Àå °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå : Áúº´ Ä¡·á À¯Çüº°

  • ±Þ¼º ½ÅÀ庴
  • ¸¸¼º ½ÅÀ庴

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦112Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¡Á¤¿ë Åõ¼® ½Ã½ºÅÛ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Awak Technologies Pte. Ltd.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Braun Melsungen AG
  • Cantel Medical Corporation
  • DaVita Inc.
  • Europlaz Technologies Ltd
  • Fresenius Medical Care AG & Co. KGaA
  • Medical Information Technology, Inc.
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Outset Medical
  • Quanta Dialysis Technologies
LSH

The Home Dialysis Systems Market was valued at USD 22.34 billion in 2023, expected to reach USD 24.59 billion in 2024, and is projected to grow at a CAGR of 10.53%, to USD 45.04 billion by 2030.

The home dialysis systems market comprises medical devices and equipment used for dialysis procedures that can be performed at a patient's residence, negating the need for frequent clinical visits. These systems primarily include peritoneal dialysis and home hemodialysis equipment. The rising prevalence of kidney diseases, the growing geriatric population, and the increasing preference for home healthcare services underscore the necessity of these systems. They provide patients with the convenience and comfort of staying home, while still receiving necessary treatments. The end-use scope includes individual patients, healthcare providers, and home healthcare agencies. Key factors driving growth in this market are increased awareness of home dialysis benefits, advancements in telehealth, and supportive governmental policies. Emerging opportunities exist in technology integration such as IoT and AI-driven systems that ensure better monitoring and predictive maintenance, enhancing patient outcomes. However, challenges persist, including high initial costs, lack of patient awareness in developing regions, and potential compliance and safety concerns. Additionally, reimbursement issues and the requirement for skilled caregivers can hinder market penetration. To overcome these challenges, companies should focus on innovations such as developing cost-effective solutions, enhancing user-friendly interfaces, and expanding educational initiatives to increase patient and provider awareness. Research into miniaturization of devices and improvement of wearable dialysis systems can provide competitive advantages. The nature of the home dialysis systems market is dynamic and increasingly technology-driven, with potential for significant growth driven by patient-centric innovations and improvements in healthcare infrastructure. Collaborative ventures with technology firms and healthcare providers can facilitate product enhancements and broaden market reach. Stakeholders should focus on addressing regulatory guidelines and invest in R&D activities to foster innovation and expand their product portfolios.

KEY MARKET STATISTICS
Base Year [2023] USD 22.34 billion
Estimated Year [2024] USD 24.59 billion
Forecast Year [2030] USD 45.04 billion
CAGR (%) 10.53%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Home Dialysis Systems Market

The Home Dialysis Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic kidney disease worldwide
    • Significant adoption attributed to convenience and flexibility of patients
    • Favorable government programs for home dialysis
  • Market Restraints
    • Associated high cost of home dialysis systems
  • Market Opportunities
    • Emergence of innovative and advanced home dialysers systems
    • Implementation of consumer friendly technology in home dialysis system
  • Market Challenges
    • High preference towards the center dialysis rather than home dialysis

Porter's Five Forces: A Strategic Tool for Navigating the Home Dialysis Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Home Dialysis Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Home Dialysis Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Home Dialysis Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Home Dialysis Systems Market

A detailed market share analysis in the Home Dialysis Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Home Dialysis Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Home Dialysis Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Home Dialysis Systems Market

A strategic analysis of the Home Dialysis Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Home Dialysis Systems Market, highlighting leading vendors and their innovative profiles. These include Awak Technologies Pte. Ltd., Baxter International Inc., Becton, Dickinson and Company, Braun Melsungen AG, Cantel Medical Corporation, DaVita Inc., Europlaz Technologies Ltd, Fresenius Medical Care AG & Co. KGaA, Medical Information Technology, Inc., Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical, Inc., Outset Medical, and Quanta Dialysis Technologies.

Market Segmentation & Coverage

This research report categorizes the Home Dialysis Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Device. The Consumables is further studied across Bloodlines, Catheters, and Concentrates. The Device is further studied across Dialyzers, Machine, and Water Treatment System.
  • Based on Dialysis Type, market is studied across Hemodialysis and Peritoneal Dialysis. The Hemodialysis is further studied across Conventional, Nocturnal Hemodialysis, and Short Daily Hemodialysis. The Peritoneal Dialysis is further studied across Ambulatory Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis.
  • Based on Disease Treatment Type, market is studied across Acute Kidney Disease and Chronic Kidney Disease.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic kidney disease worldwide
      • 5.1.1.2. Significant adoption attributed to convenience and flexibility of patients
      • 5.1.1.3. Favorable government programs for home dialysis
    • 5.1.2. Restraints
      • 5.1.2.1. Associated high cost of home dialysis systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of innovative and advanced home dialysers systems
      • 5.1.3.2. Implementation of consumer friendly technology in home dialysis system
    • 5.1.4. Challenges
      • 5.1.4.1. High preference towards the center dialysis rather than home dialysis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Home Dialysis Systems Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Bloodlines
    • 6.2.2. Catheters
    • 6.2.3. Concentrates
  • 6.3. Device
    • 6.3.1. Dialyzers
    • 6.3.2. Machine
    • 6.3.3. Water Treatment System

7. Home Dialysis Systems Market, by Dialysis Type

  • 7.1. Introduction
  • 7.2. Hemodialysis
    • 7.2.1. Conventional
    • 7.2.2. Nocturnal Hemodialysis
    • 7.2.3. Short Daily Hemodialysis
  • 7.3. Peritoneal Dialysis
    • 7.3.1. Ambulatory Peritoneal Dialysis
    • 7.3.2. Continuous Ambulatory Peritoneal Dialysis

8. Home Dialysis Systems Market, by Disease Treatment Type

  • 8.1. Introduction
  • 8.2. Acute Kidney Disease
  • 8.3. Chronic Kidney Disease

9. Americas Home Dialysis Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Home Dialysis Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Home Dialysis Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Awak Technologies Pte. Ltd.
  • 2. Baxter International Inc.
  • 3. Becton, Dickinson and Company
  • 4. Braun Melsungen AG
  • 5. Cantel Medical Corporation
  • 6. DaVita Inc.
  • 7. Europlaz Technologies Ltd
  • 8. Fresenius Medical Care AG & Co. KGaA
  • 9. Medical Information Technology, Inc.
  • 10. Nikkiso Co., Ltd.
  • 11. Nipro Corporation
  • 12. NxStage Medical, Inc.
  • 13. Outset Medical
  • 14. Quanta Dialysis Technologies
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦